Literature DB >> 17060726

Technical and anatomical considerations of face harvest in face transplantation.

Alessio Baccarani1, Keith E Follmar, Steffen P Baumeister, Jeffrey R Marcus, Detlev Erdmann, L Scott Levin.   

Abstract

Total face transplantation may become a reconstructive option in the treatment of patients with acquired facial deformity. Here, 2 face-harvesting techniques are presented in a fresh human cadaver model. In technique 1, the skin and soft tissue of the face is harvested by dissecting in a subgaleal, sub-SMAS, subplatysmal plane. In technique 2, the entire soft tissue and the bony structures of the midface are harvested by dissecting in a subperiosteal plane and performing a Le Fort III osteotomy. Each face was harvested successfully as a bipedicled flap based on the external carotid arteries, the external jugular veins, and the facial veins. Each of these 2 techniques is a theoretically viable approach to face harvest for composite allograft transplantation. These techniques represent the 2 extremes of which tissues can be harvested while maintaining vascular integrity. Each will address different reconstructive needs.

Entities:  

Mesh:

Year:  2006        PMID: 17060726     DOI: 10.1097/01.sap.0000227486.28556.3e

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  [Facial allograft transplantation: fiction or reality? Surgical techniques in a fresh human cadaver model].

Authors:  C Messmer; A Baccarani; K E Follmar; S Mukundan; L S Levin; J R Marcus; D Erdmann
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

Review 2.  Vascularized Composite Allografts: Procurement, Allocation, and Implementation.

Authors:  Axel Rahmel
Journal:  Curr Transplant Rep       Date:  2014

3.  The transverse facial artery anatomy: Implications for plastic surgery procedures.

Authors:  Mateusz Koziej; Jakub Polak; Jakub Wnuk; Marek Trybus; Jerzy Walocha; Anna Chrapusta; Paweł Brzegowy; Ewa Mizia; Tadeusz Popiela; Mateusz Hołda
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.